Yes - but the quarterly due not later than 30 April will give us the quarterly activities to end March. Hopefully they will split the normal clinical business from anything derived from trials. One of the problems with the RHT reporting is that it is very difficult to get a handle on 'underlying' growth.
Yes - but the quarterly due not later than 30 April will give us...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
3.6¢ |
Change
0.000(0.00%) |
Mkt cap ! $16.54M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 7981 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.0¢ | 245471 | 1 |
View Market Depth
| Last trade - 10.00am 07/08/2025 (20 minute delay) ? |
| RHT (ASX) Chart |
Day chart unavailable